(Q80531956)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

clear cell adenocarcinoma

1 January 2020

main subject

1 reference

based on heuristic

inferred from title

ovarian clear cell adenocarcinoma

1 reference

Hiroshi Tanabe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hiroshi Nishii

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Akihiko Sakata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Keitaro Suzuki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yukiko Mori

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hideo Shinozaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Akihiko Watanabe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kazuhiko Ochiai

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Makoto Yasuda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Tadao Tanaka

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

735-739

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

inferred from DOI database lookup

7 January 2021

based on heuristic

Prognostic significance of HER-2/neu expression in advanced epithelial ovarian cancer: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

Expression of HER-2/neu oncoprotein, DNA-ploidy and S-phase fraction in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

HER-2/neu expression in ovarian clear cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

NEU protein overexpression in benign, borderline, and malignant ovarian neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

HER2 is frequently over-expressed in ovarian clear cell adenocarcinoma: possible novel treatment modality using recombinant monoclonal antibody against HER2, trastuzumab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.055

10.1016/J.YGYNO.2004.05.055

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350366%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference